Michael Best & Friedrich LLP
Compounds as calcium channel blockers
The present application relates to calcium channel inhibitors containing compounds of formula (I)wherein Ar1, Ar2, L1, L2, n, R1, R4, X and Y are as defined in the specification. The present application also relates to compositions comprising such compounds, and methods of treating conditions and disorders using such compounds and compositions.
Abbott Laboratories Abbott GmbH & Co. KG
A C A C A A A C C C A A A A C A A C C C C A A A C A A A A C A A A A A C A C A C C A A C C A A
A61P C07D A61P C07D A61P A61P A61P C07D C07D C07D A61P A61P A61P A61P C07D A61P A61P C07D C07D C07D C07D A61P A61P A61P C07D A61P A61P A61P A61P C07D A61P A61P A61P A61P A61P C07D A61P C07D A61P C07D C07D A61P A61P C07D C07D A61P A61P
inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Helmut Pramila A. Irene Richard J. George A. Qingwei Andrew O.
Mack Bhatia Drizin Perner Doherty Zhang Stewart